Iron is essential, it carries oxygen in your blood, powers your mitochondria, and supports your immune system. But unlike most nutrients, your body has no active mechanism to excrete excess iron. Once it is in, it stays in. For most people this is fine, because absorption is tightly regulated. For those who carry two faulty copies of the HFE gene, that regulation breaks down, and iron slowly accumulates in the liver, heart, pancreas, joints and skin over decades.
Hereditary haemochromatosis is the most common inherited disorder in people of Northern European descent, yet it is dramatically underdiagnosed. Its early symptoms, fatigue and joint pain, are so common and non-specific that most carriers go years without knowing. The good news: it is also one of the most treatable genetic conditions, caught early, it is managed with a simple, ancient remedy: removing blood.
What the HFE Gene Does
The HFE gene, on chromosome 6, produces a protein that helps your body sense how much iron it already has. It acts upstream of hepcidin, the master hormone that regulates iron absorption. When stores are high, hepcidin rises and tells the gut to absorb less. When HFE is defective, this signal is blunted: hepcidin stays inappropriately low, and the intestine keeps absorbing iron as if the body were perpetually deficient. The result is a slow, silent overload. A healthy adult body holds 3–4 g of iron; someone with untreated haemochromatosis can accumulate 20 g or more, and that excess generates oxidative stress that damages the organs where it deposits.
The Two Key Variants: C282Y and H63D
Around 85–90% of cases are explained by two HFE variants:
- C282Y / C282Y (homozygous): the major, high-risk genotype. Roughly 1 in 200 to 1 in 300 people of Northern European, especially Irish and Celtic, ancestry are affected; about 1 in 10 carry a single copy.
- C282Y / H63D (compound heterozygous): a modest, variable risk, usually only progressing with additional factors such as alcohol or fatty liver disease.
- H63D alone or single variants: generally low risk.
Carrying the genotype is not the same as having the disease. Penetrance is incomplete, many C282Y homozygotes never develop clinical overload. Your genes flag a predisposition; your blood markers confirm whether it is expressed.
Why Men and Women Differ
Women are partially protected for much of their lives because menstruation and pregnancy regularly remove iron. They typically present later, often after menopause, while men can show signs from their 30s and 40s, a clear example of one fixed genotype producing very different outcomes depending on physiology.
The Symptoms to Recognise
- Persistent fatigue, the most common early sign
- Joint pain, classically in the knuckles of the first two fingers (“the iron fist”)
- Bronze or grey skin pigmentation
- Elevated liver enzymes, progressing in severe cases to cirrhosis and higher liver-cancer risk
- Type 2 diabetes (“bronze diabetes”) from iron damage to the pancreas
- Loss of libido, erectile dysfunction, sometimes cardiomyopathy or hypothyroidism
How It Is Confirmed: Beyond the Gene
Genetic status alone does not diagnose overload. Two inexpensive blood tests do the real work:
- Transferrin saturation (TSAT): a fasting value above ~45% is an early warning sign.
- Serum ferritin: reflects total iron stores; persistently elevated ferritin alongside high TSAT points to genuine overload (ferritin also rises with inflammation, so the two are read together).
The Gold-Standard Treatment
The primary treatment is therapeutic phlebotomy, removing a unit of blood regularly until iron stores normalise, then maintaining with occasional sessions. Each unit removes roughly 200–250 mg of iron. Caught before organ damage, phlebotomy gives most people a normal life expectancy. Diet is a supporting actor, not the main treatment.
Nutrition: The Adjustments That Actually Matter
- Do not take iron supplements or multivitamins containing iron.
- Separate high-dose vitamin C from iron-rich meals, vitamin C sharply increases non-heme iron absorption (the vitamin C in a normal varied diet is fine; concentrated doses are the issue).
- Use tea and coffee strategically, their polyphenols and tannins reduce iron absorption when taken with meals.
- Moderate heme iron from red and organ meats, it is absorbed regardless of body stores. No need to become vegetarian; avoid excess.
- Limit alcohol, it increases iron absorption and compounds liver damage.
- Avoid raw shellfish. People with iron overload are far more vulnerable to Vibrio vulnificus, a bacterium in raw oysters that thrives in iron-rich blood and can cause life-threatening infection. Cook your shellfish.
- Calcium and dietary phytates also modestly lower iron absorption with meals.
The goal is not to starve yourself of iron, that risks other deficiencies, and phlebotomy remains the main tool. The point is to stop pouring fuel on the fire.
The Connection With Your FuelYourDNA Profile
HFE is one of the highest-value genes in a nutrition report because the action it points to is so concrete. If your profile flags an at-risk C282Y or compound genotype, the single most useful next step is simple: ask your doctor for a fasting transferrin saturation and ferritin panel. From there, the dietary levers above become genuinely meaningful rather than generic advice.
Few genetic findings are as actionable as HFE: a cheap blood test confirms it, a centuries-old treatment reverses it, and a handful of dietary habits slow it. The only real danger is not knowing.
Key Takeaways
- HFE variants C282Y and H63D explain ~85–90% of hereditary haemochromatosis; C282Y homozygosity is the main high-risk genotype
- The body cannot excrete excess iron, so it slowly overloads the liver, heart, pancreas and joints over decades
- Genotype is a predisposition, not a diagnosis, transferrin saturation and ferritin confirm whether overload is real
- Therapeutic phlebotomy is highly effective when started early; diet is a supporting measure
- Key dietary levers: avoid iron supplements, separate high-dose vitamin C from meals, use tea/coffee with meals, moderate alcohol and red meat, and never eat raw shellfish
Scientific References
Key research informing this article includes the original identification of the HFE gene, large population studies on the penetrance of iron overload, and clinical practice guidelines from the AASLD and EASL.
Scientific References
- Feder JN, et al. (1996). A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13(4), 399–408. PubMed 8696333
- Adams PC, et al. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. New England Journal of Medicine, 352(17), 1769–1778. PubMed 15858186
- Allen KJ, et al. (2008). Iron-overload–related disease in HFE hereditary hemochromatosis. New England Journal of Medicine, 358(3), 221–230. PubMed 18199861
- Pietrangelo A. (2010). Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology, 139(2), 393–408. PubMed 20542038
- Bacon BR, et al. (2011). Diagnosis and management of hemochromatosis: 2011 AASLD practice guideline. Hepatology, 54(1), 328–343. PubMed 21452290
- Powell LW, et al. (2016). Haemochromatosis. The Lancet, 388(10045), 706–716. PubMed 26975792